loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Fusidic Acid

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Fusidic Acid

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 824Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Request to take over the Fucidin marketing authorisation
    Request to take over the Fucidin marketing authorisation

    30 Mar 2020

    // CBG

    https://english.cbg-meb.nl/latest/news/2020/03/31/request-to-take-over-the-fucidin-marketing-authorisation

    CBG
    30 Mar 2020
    Share Share
    NICE recommends antiseptics over antibiotics for impetigo
    NICE recommends antiseptics over antibiotics for impetigo

    23 Aug 2019

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/nice_recommend_antiseptics_over_antibiotics_for_impetigo_1298973

    Anna Smith PHARMA TIMES
    23 Aug 2019
    Share Share